Galli, E. et al. 2022. [Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]. Farmeconomia. Health economics and therapeutic pathways. 23, 1 (Jun. 2022). DOI:https://doi.org/10.7175/fe.v23i1.1527.